• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Glaucoma - Articles and news items

transcend-medical

Eye care company Alcon acquires Transcend Medical

Industry news / 18 February 2016 / Victoria White

This Transcend Medical acquisition also expands Alcon’s leadership in glaucoma and cataract treatment…

aquesys

Allergan to acquire glaucoma treatment company AqueSys

Industry news / 4 September 2015 / Victoria White

Allergan is to acquire AqueSys for a $300 million upfront payment and milestone payments related to AqueSys’ lead development programmes, including XEN45…

glaucoma

Glaucoma treatment market value will grow moderately to $3 billion by 2023

Industry news / 10 June 2015 / Victoria White

The treatment market for glaucoma will rise in value from $2.4 billion in 2013 to approximately $3 billion by 2023 across the seven major markets…

ISTH0036

Isarna initiates first-in-human Phase I trial for ISTH0036 to treat advanced glaucoma

Industry news / 16 April 2015 / Victoria White

Isarna has initiated the Phase I clinical trial with ISTH0036, an antisense oligonucleotide selectively targeting TGF-ß2 to treat advanced glaucoma…

ISTH0036

Aerie Pharmaceuticals completes enrollment in second Phase 3 registration trial of Rhopressa

Industry news / 24 March 2015 / Victoria White

Aerie Pharmaceuticals has announced the completion of enrollment in the Company’s second Phase 3 registration trial (“Rocket 2”) of Rhopressa…

Santen

Santen establishes subsidiary in United Kingdom

Industry news / 4 November 2014 / Santen Pharmaceutical Co

Santen Pharmaceutical Co., Ltd. announced the establishment of a wholly owned subsidiary in The United Kingdom (UK) to serve customers and patients in the UK and Ireland…

Santen

Santen announces positive outcome of the European Decentralized Procedure for approval of TAPTIQOM®

Industry news / 23 October 2014 / Santen

Santen GmbH. announced the positive outcome of the Decentralized Procedure (DCP) for TAPTIQOM® in Europe…

Santen

Santen launches its own Subsidiary in Italy

Industry news / 16 October 2014 / Santen Pharmaceutical Co

Santen Pharmaceutical Co., Ltd. announced its new wholly owned subsidiary in Italy…

Celerion

Celerion expands ophthalmological capabilities to patient populations in collaboration with Queen’s University, Belfast

Industry news / 30 September 2014 / Celerion

Celerion, announces the expansion of ophthalmological services in our Belfast, Northern Ireland UK facility, by building on our successful relationship with Queen’s University in Belfast…

Alcon Logo

Alcon’s Simbrinza® approved in the EU to treat patients living with glaucoma, a chronic sight-threatening eye disease

Industry news / 4 August 2014 / Novartis

Alcon announced that Simbrinza® eye drops suspension (brinzolamide 10mg/mL and brimonidine tartrate 2mg/mL) has been approved by the European Commission to decrease elevated intraocular pressure…

Novartis

Alcon’s Simbrinza® approved in the EU to treat patients living with glaucoma, a chronic sight-threatening eye disease

Industry news / 28 July 2014 / Novartis

Alcon, the global leader in eye care and a division of Novartis, announced that Simbrinza® eye drops suspension (brinzolamide 10mg/mL and brimonidine tartrate 2mg/mL) has been approved by the European Commission…

Alcon Logo

Alcon announces FDA approval of Simbrinza(TM) Suspension

Industry news / 19 April 2013 / Novartis

A new beta blocker-free, fixed-combination therapy for glaucoma patients…

  • Page 1 of 2
  • 1
  • 2
  • >

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +